Pfizer Limited
Pfizer Limited (PFIZER.NS) Stock Overview
Explore Pfizer Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
232.9B
P/E Ratio
27.29
EPS (TTM)
$186.63
ROE
0.21%
PFIZER.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Pfizer Limited (PFIZER.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.09, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5015.61.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.29 and a market capitalization of 232.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.